Do you know someone who would make a good ASCO President, Board member, or Nominating Committee member? In advance of the upcoming election, the ASCO Nominating Committee is seeking recommendations ...

“This trial emphasizes the importance of germline and somatic testing in patients with metastatic prostate cancer at the time of diagnosis; homologous recombination repair mutations have been ...

“This early but promising observational study suggests a powerful synergy: patients with stage III colon cancer who embraced anti-inflammatory foods and exercised regularly showed the best overall ...

“This is the first randomized phase 3 trial in patients with stage III and high-risk stage II colon cancer to demonstrate that post-treatment exercise is both achievable and effective in improving ...

An internationally recognized oncology leader and health care executive, Dr. Knudsen is the CEO of the Parker Institute for Cancer Immunotherapy. Dr. Knudsen was previously CEO of the American Cancer ...

Main Takeaway Perioperative treatment with durvalumab (Imfinzi) and chemotherapy led to longer survival without cancer recurrence, progression or treatment-related complications for patients with ...

Launched in 2016, this award program honors extraordinary women leaders in oncology and role models who have excelled as mentors and have demonstrated outstanding commitment to the development of the ...

“Trastuzumab deruxtecan is approved for patients with metastatic HER2-positive gastric cancer or gastroesophageal junction adenocarcinoma who received a prior trastuzumab-based regimen based on ...

Today the administration released the details of its proposed FY 2026 budget request, including a nearly 40% reduction in funding for the National Institutes of Health (NIH) and the National Cancer ...

ALEXANDRIA, Va., and SUNNYVALE, Calif.– The American Society of Clinical Oncology (ASCO) and Google Cloud today announced a powerful collaboration to launch an AI-based ASCO Guidelines Assistant.

“This study shows that sacituzumab govitecan, when combined with pembrolizumab as an initial treatment for patients with metastatic triple-negative breast cancer, delivers superior disease control and ...

The Minnesota Society of Clinical Oncology (MSCO) is the recipient of the 2024 Jeffery C. Ward Affiliate Advocacy Award. The Association for Clinical Oncology presented the award during the State ...